
The Acute Care™ CK-MB assay is an in vitro diagnostic test for the measurement of the MB iso-enzyme of creatine kinase in heparinized whole blood/plasma. CK-MB measurements can be used as an aid in diagnosing acute myocardial infarction.
CK-MB is found primarily in cardiac tissue.1 CK-MB can be detected at elevated concentrations following myocardial damage. Abnormal plasma CK-MB concentrations are often associated with ischemia or necrotic heart injury. The increase in CK-MB concentration is often evident within 3 to 6 hours following onset of chest pain, reaching peak concentrations within 12 to 24 hours. CK-MB concentrations will generally return to normal within 24 to 72 hours.2 The determination of CK-MB is most beneficial when samples have been drawn at appropriate time intervals post onset of chest pain.
βhCG |
|
Assay Range |
0.3 – 150ng/mL (µg/L) |
Sensitivity |
0.3 ng/mL |
Reproducibility (CV) |
4.0% at 3.7 ng/mL |
Calibration Stability |
60 days |
DilPak™ Automatic Dilution |
Yes |
Sodium Heparin Tubes |
Yes |
Lithium Heparin Tubes |
Yes |
Loading...
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
Cero Generation Launches 70MW Agrivoltaic Project in Italy with Support from Philips & HEINEKEN
Cero Generation’s 70MW agrivoltaic solar PV project in Province of Latina... Read more
Agamon Health Partners with Mayo Clinic to Bridge Cardiology Gaps Using AI Know-How
Agamon Health's Patient Adherence platform is aimed at raising standards... Read more
Hologic & Bayer Partner for Global Enhanced Mammography Solutions to Imaging Centers
Partnership Includes Education and Training to Increase Clinician Confidence... Read more
Breast cancer: more cases detected with the help of AI
One radiologist supported by AI detected more cases of breast cancer... Read more
Championing Billions of Women Through the Hologic Global Women’s Health Index
The invitation proved too momentous to pass up. It arrived as... Read more
JOIN OUR MANAGEMENT COMMUNITY
MediView Announces New Board Member
MediView is pleased to announce the addition of Karley Yoder as a new... Read more
Foldax Appoints Scott Huennekens to Board of Directors
Foldax®, Inc. has announced the appointment of medical device veteran... Read more
Dr Gregor Smith: Scotland’s New Interim CMO
Dr Gregor Smith has been appointed Scotland's interim Chief Medical... Read more
NICE Appoints New CEO
The UK’s National Institute for Health and Care Excellence (NICE)... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
JOIN OUR MANAGEMENT COMMUNITY